Evaluation of secondary malignancies in a large series of mycosis fungoides

Abstract Background An increased risk of Secondary Malignancies (SMs) in Mycosis Fungoides (MF) has been suggested previously. However, the relationship between this risk and the features of MF is not well-known. Objective To investigate the rate and types of SMs in a large cohort of MF patients foc...

Full description

Saved in:
Bibliographic Details
Main Authors: Tugba Atci (Author), Dilay Yerlioğlu Ak (Author), Can Baykal (Author)
Format: Book
Published: Sociedade Brasileira de Dermatologia, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4d46cb8c64a84bafab0d5c0435c04e4e
042 |a dc 
100 1 0 |a Tugba Atci  |e author 
700 1 0 |a Dilay Yerlioğlu Ak  |e author 
700 1 0 |a Can Baykal  |e author 
245 0 0 |a Evaluation of secondary malignancies in a large series of mycosis fungoides 
260 |b Sociedade Brasileira de Dermatologia,   |c 2024-05-01T00:00:00Z. 
500 |a 0365-0596 
500 |a 10.1016/j.abd.2023.06.004 
520 |a Abstract Background An increased risk of Secondary Malignancies (SMs) in Mycosis Fungoides (MF) has been suggested previously. However, the relationship between this risk and the features of MF is not well-known. Objective To investigate the rate and types of SMs in a large cohort of MF patients focusing on the associated features of these patients. Methods The demographic features, subtype, and stage of MF, as well as the temporal relationship between the diagnosis of MF and the development of SMs were determined. Major clinical features of MF in this group were compared with MF patients without association of SMs. Results Among 730 MF patients with a mean follow-up period of 67.9 ± 52.4 months, 56 SMs were identified in a total of 52 (7.1%) patients. While 28.8% of patients were previously diagnosed with other malignancies, then subsequently had a diagnosis of MF, it was vice versa in 53.8% of patients. Most of the SM-associated MF patients had early-stage (80.7%) and classical type of MF (86.5%) without a significant difference from MF patients without association of SMs; 85.5% and 72.5%, respectively. The most commonly identified SMs were hematologic malignancies (64.3%) including lymphomatoid papulosis (n = 22), Hodgkin's lymphoma (n = 4), non-Hodgkin's lymphoma (n = 5), polycythemia vera (n = 2). Other most commonly associated malignancies were breast cancer (n = 4), prostate cancer (n = 3), renal cell carcinoma (n = 2), melanoma (n = 2), and Kaposi's sarcoma (n = 2). Study limitations A single tertiary dermatology center study with a retrospective design. Conclusion Apart from the well-known lymphomatoid papulosis association, systemic hematological malignancies were also quite common in the large cohort of MF patients. 
546 |a EN 
546 |a PT 
690 |a Hematologic neoplasms 
690 |a Lymphomatoid papulosis 
690 |a Mycosis fungoides 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Anais Brasileiros de Dermatologia, Vol 99, Iss 3, Pp 370-379 (2024) 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962024000300370&tlng=en 
787 0 |n https://doaj.org/toc/0365-0596 
856 4 1 |u https://doaj.org/article/4d46cb8c64a84bafab0d5c0435c04e4e  |z Connect to this object online.